Skip to content

Anxiety & Depression in Thyroid Cancer Patients

Anxiety, Depression and Quality of Life in Thyroid Cancer Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06269731
Enrollment
159
Registered
2024-02-21
Start date
2024-03-31
Completion date
2026-03-31
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer

Keywords

depression, anxiety

Brief summary

1. To identify the prevalence of both anxiety and depression in thyroid cancer patients 2. To assess quality of life in thyroid cancer patients

Detailed description

In recent years, increasing attention has been paid to mental health among cancer patients. Thyroid cancer is one of the most frequent endocrine neoplasia. It consists of 4 subtypes of papillary thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, and anaplastic thyroid cancer. Which is usually asymptomatic in the early stages, but symptoms such as neck pain, hoarseness, and dysphagia may occur as the disease progresses. TC is diagnosed by physical examination, analysis of thyroid hormone levels, imaging, and biopsy. Anxiety and depression are the most common psychological problems in the treatment of cancer patients and are related to the majority of medical diseases and physical symptoms. Studies have suggested that anxiety and depression are common in patients with thyroid cancer. Therefore, quality of life which includes psychological, social, and spiritual well-being, has become an important consideration . These findings highlight the importance of identifying thyroid cancer patients needs to allow better and more adequate care and support.

Interventions

also known as the Ham-D is the most widely used clinician-administered depression assessment scale. The original version contains 17 items (HDRS17) pertaining to symptoms of depression experienced over the past week. Although the scale was designed for completion after an unstructured clinical interview, The scale has been translated into a number of languages including French, German, Italian, Thai , Turkish and Arabic version by Mostafa Lotfy.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

1. Age at or more than 18 years old 2. None of the patients had history of other psychiatric illness 3. Both sex 4. Accept to participate in the study

Exclusion criteria

1. Age less than 18 years old 2. Previous history of other psychiatric illness 3. substance abuser or dependence 4. Refuse to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
the prevalence of anxiety in thyroid cancer patientsbaselineTo identify the prevalence of anxiety in thyroid cancer patients by using Hamilton Anxiety Rating Scale
the prevalence of depression in thyroid cancer patientsbaselineTo identify the prevalence of depression in thyroid cancer patients by using Hamilton Depression Rating Scale

Secondary

MeasureTime frameDescription
assess quality of life in thyroid cancer patientsbaselineDetect quality of life in patients with thyroid cancer by using Short form 36 Quality of life questionnaire

Contacts

Primary Contactsalma mamdouh
salmamamdouhmm@gmail.com+201016297915

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026